Warning: The NCBI web site requires JavaScript to function. more...
Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?
Gaffo AL, Edwards NL, Saag KG.
Arthritis Res Ther. 2009;11(4):240. Epub 2009 Aug 19. Review.
Related citations
[Uric acid and cardiorenal risk: marker or cause?].
Bellomo G, Venanzi S, Timio M.
G Ital Nefrol. 2011 Mar-Apr;28(2):157-65. Review. Italian.
Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
Shah A, Keenan RT.
Curr Rheumatol Rep. 2010 Apr;12(2):118-24. Review.
The role of hyperuricemia and gout in kidney and cardiovascular disease.
Edwards NL.
Cleve Clin J Med. 2008 Jul;75 Suppl 5:S13-6. Review.
[Is hyperuricemia a cardiovascular risk factor?].
Chizyński K, Rózycka M.
Wiad Lek. 2006;59(5-6):364-7. Review. Polish.
Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB.
Am J Kidney Dis. 1999 Feb;33(2):225-34. Review.
[Hyperuricemia and the metabolic syndrome].
Mitu F, Drăgan MV.
Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1001-5. Romanian.
Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
Keenan RT, Pillinger MH.
Bull NYU Hosp Jt Dis. 2009;67(3):285-90. Review.
Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.
Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M.
BMC Public Health. 2004 Mar 25;4:9.
Hyperuricemia, gout and the metabolic syndrome.
Puig JG, Martínez MA.
Curr Opin Rheumatol. 2008 Mar;20(2):187-91. Review.
[Contribution of the CoLaus study to decipher the determinants of serum uric acid].
Bochud M, Vollenweider P, Waeber G.
Rev Med Suisse. 2011 Nov 2;7(315):2142, 2144-5. French.
Uric acid in heart disease: a new C-reactive protein?
Krishnan E, Sokolove J.
Curr Opin Rheumatol. 2011 Mar;23(2):174-7. Review. Erratum in: Curr Opin Rheumatol. 2011 Jul;23(4):410.
Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout.
Krishnan E.
Rheumatology (Oxford). 2010 Jul;49(7):1229-38. Epub 2010 Mar 3. Review.
Comment on: Gout: an independent risk factor for all-cause and cardiovascular mortality.
Mascitelli L, Pezzetta F, Goldstein MR.
Rheumatology (Oxford). 2010 Jul;49(7):1421-2; author reply 1422. Epub 2010 Apr 27. No abstract available.
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M.
Hypertension. 2003 Jun;41(6):1183-90. Epub 2003 Apr 21. Review.
Medical implications of hyperuricemia.
Sachs L, Batra KL, Zimmermann B.
Med Health R I. 2009 Nov;92(11):353-5. Review. No abstract available.
Genetic factors associated with gout and hyperuricemia.
Bleyer AJ, Hart TC.
Adv Chronic Kidney Dis. 2006 Apr;13(2):124-30. Review.
Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
Viazzi F, Leoncini G, Ratto E, Pontremoli R.
J Clin Hypertens (Greenwich). 2006 Jul;8(7):510-8. Review.
Altered uric acid levels and disease states.
Kutzing MK, Firestein BL.
J Pharmacol Exp Ther. 2008 Jan;324(1):1-7. Epub 2007 Sep 21. Review.
New insights into gout epidemiology.
Mikuls TR, Saag KG.
Curr Opin Rheumatol. 2006 Mar;18(2):199-203. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on